Bausch & Lomb launches eye care spinoff

Bausch & Lomb launched an initial public offering for its eye care spinoff company, MarketWatch reported April 28.

The new company will separate the fast-growing eye business from Bausch Health's pharmaceutical business, the report said. The initial public offering values the company at $8.4 billion.

The spinoff has been planned since at least 2020, the report said.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast